Live Breaking News & Updates on Nektar Therapeutics

Stay updated with breaking news from Nektar therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer

Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , John-hayslip , Louisj-denis , Dan-paterson , University-of-south-carolina , University-of-kentucky-markey-cancer-center , Exchange-commission , Ohio-medical-university , Secura-bio-inc , Linkedin , Leukemia-research

Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer

Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of John Hayslip, M.D., an accomplished oncologist with deep clinical research, development, and. ....

Ohio , United-states , John-hayslip , Dan-paterson , Louisj-denis , Secura-bio-inc , University-of-south-carolina , University-of-kentucky-markey-cancer-center , Chugai-pharmaceutical-co-ltd , Company-annual-report-on-form , Nektar-therapeutics , Exchange-commission

Nektar Therapeutics to Post FY2026 Earnings of ($0.95) Per Share, Zacks Research Forecasts (NASDAQ:NKTR)

Nektar Therapeutics to Post FY2026 Earnings of ($0.95) Per Share, Zacks Research Forecasts (NASDAQ:NKTR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , William-blair , Zacks-research , Nektar-therapeutics , Capital-partners , Jefferies-financial-group , Acadian-asset-management , Free-report , Nektar-therapeutic , Get-free-report , Asset-management , Nektar-therapeutics-daily

Vivani Medical : 2024 Investor Presentation -March 26, 2024 at 12:01 pm EDT

Disclaimers


The following slides and any accompanying oral presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act. ....

Boston , Massachusetts , United-states , Berkeley , California , Rhone-poulenc-rorer , Richard-vosser , Donald-dwyer , Lisa-porter , Truc-le , Boston-scientific , Nektar-therapeutics